So if and when the Viraleze results of trial are actually released it will be interesting to compare with other larger scale trials that have been conducted in last few years. This trial design was deemed impossible by SPL posters would have been considered unethical from memory?
Here is the one for pHOXWELL’s clinical trial involving at-risk, unvaccinatedhealthcare workers conducted in 2021 and peer reviewed and published July 2022. How well is it selling?
I hope other posters can pull up some more trials so SPL shareholders know where the hurdle is that they need to exceed to be the gold standard of nasal sprays I'll leave it to someone else to post up the biosure trial or just for fun the animal study on Siberian Hamsters
"The paper, entitled “Evaluating the efficacy and safety of a novel prophylacticnasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind,placebo-controlled, randomised trial” has been peer-reviewed. The paper focuses on pHOXWELL’s clinical trial involving at-risk, unvaccinatedhealthcare workers in India which showed the spray reduced SARS-CoV-2infections by 62% compared to placebo." https://www.sciencedirect.com/science/article/pii/S1386653222001809
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)